Anti-SUCLA2/Renal carcinoma antigen NYREN39/FITC Conjugated抗体
产品名称: Anti-SUCLA2/Renal carcinoma antigen NYREN39/FITC Conjugated抗体
英文名称: Anti-SUCLA2/Renal carcinoma antigen NYREN39/FITC
产品编号: YB--12838R-FITC
产品价格: null
产品产地: 中国/美国
品牌商标: Ybscience
更新时间: 2023-08-17T10:29:50
使用范围: 科研使用
上海钰博生物科技有限公司
- 联系人 : 陈环环
- 地址 : 上海市沪闵路6088号龙之梦大厦8楼806室
- 邮编 : 200612
- 所在区域 : 上海
- 电话 : 183****2235 点击查看
- 传真 : 点击查看
- 邮箱 : shybio@126.com
- 二维码 : 点击查看
Anti-SUCLA2/Renal carcinoma antigen NYREN39/FITC Conjugated抗体
产品编号 | YB-12838R-FITC |
英文名称 | Anti-SUCLA2/Renal carcinoma antigen NYREN39/FITC |
中文名称 | FITC标记的肾细胞癌抗原nyren39抗体 |
别 名 | ATP specific succinyl CoA synthetase subunit beta; ATP-specific succinyl-CoA synthetase subunit beta; Renal carcinoma antigen NY-REN-39; Renal carcinoma antigen NYREN39; SCS betaA; SCS-betaA; SUCB1_HUMAN; Succinyl CoA ligase [ADP-forming] subunit beta, mitochondrial; Succinyl CoA synthetase beta A chain; Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial; Succinyl-CoA synthetase beta-A chain; SUCLA2. |
规格价格 | 100ul/2980元 购买 大包装/询价 |
说 明 书 | 100ul |
研究领域 | 细胞生物 神经生物学 信号转导 干细胞 |
抗体来源 | Rabbit |
克隆类型 | Polyclonal |
交叉反应 | Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Chimpanzee, |
产品应用 | ICC=1:50-200 IF=1:50-200 not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
分 子 量 | 45kDa |
性 状 | Lyophilized or Liquid |
浓 度 | 2mg/1ml |
免 疫 原 | KLH conjugated synthetic peptide derived from human SUCLA2/Renal carcinoma antigen NYREN39 |
亚 型 | IgG |
纯化方法 | affinity purified by Protein A |
储 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
保存条件 | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. |
产品介绍 | background: Succinyl-CoA synthetase (SCS) is a mitochondrial matrix enzyme that acts as a heterodimer, being composed of an invariant alpha subunit and a substrate-specific beta subunit. The protein encoded by this gene is an ATP-specific SCS beta subunit that dimerizes with the SCS alpha subunit to form SCS-A, an essential component of the tricarboxylic acid cycle. SCS-A hydrolyzes ATP to convert succinate to succinyl-CoA. Defects in this gene are a cause of myopathic mitochondrial DNA depletion syndrome. A pseudogene of this gene has been found on chromosome 6. [provided by RefSeq, Jul 2008] Function: Catalyzes the ATP-dependent ligation of succinate and CoA to form succinyl-CoA. Subcellular Location: Mitochondrion. Tissue Specificity: Widely expressed. DISEASE: Defects in SUCLA2 are the cause of mitochondrial DNA depletion syndrome type 5 (MTDPS5) [MIM:612073]. A disorder characterized by infantile onset of hypotonia, neurologic deterioration, a hyperkinetic-dystonic movement disorder, external ophthalmoplegia, deafness, variable renal tubular dysfunction, and mild methylmalonic aciduria. Similarity: Belongs to the succinate/malate CoA ligase beta subunit family. Contains 1 ATP-grasp domain. Database links: Entrez Gene: 8803 Human Entrez Gene: 20916 Mouse Entrez Gene: 361071 Rat Omim: 603921 Human SwissProt: Q9P2R7 Human SwissProt: Q9Z2I9 Mouse SwissProt: B2RZ24 Rat Unigene: 546323 Human Unigene: 38951 Mouse Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications |